Group 1 - The core strategy of the company is to consolidate its advantages in disposable protective products and rehabilitation equipment, with no current plans to invest in high-tech medical industries such as brain-computer interfaces or gene sequencing [1] - The company will focus on upgrading its core business technology and market expansion, and will fulfill its information disclosure obligations if there are any new business plans in the future [1]

Core Viewpoint - The company is focused on consolidating its core business in disposable protective products and rehabilitation equipment, with no current plans to invest in high-tech medical industries such as brain-computer interfaces or gene sequencing [1] Group 1 - The company responded to an investor inquiry regarding potential investments in high-tech medical sectors, stating that its current strategic focus is on strengthening its main business [1] - The company emphasized that it will concentrate on technology upgrades and market expansion within its core business [1] - The company assured that any new business plans will be disclosed in a timely manner [1]